CD115− monocytic myeloid-derived suppressor cells are precursors of OLFM4high polymorphonuclear myeloid-derived suppressor cells

[1]  S. Swaminathan,et al.  GM-CSF: A Double-Edged Sword in Cancer Immunotherapy , 2022, Frontiers in Immunology.

[2]  Xinyao Li,et al.  OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment , 2022, Oncogene.

[3]  Robin L. Anderson,et al.  Immunomodulatory effects of G-CSF in cancer: Therapeutic implications. , 2021, Seminars in immunology.

[4]  P. Papageorgis,et al.  The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities , 2021, Cancers.

[5]  Gang Zhou,et al.  Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy , 2021, Cancers.

[6]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity , 2021, Nature Reviews Immunology.

[7]  Allon M. Klein,et al.  Tumor-Promoting Ly-6G+ SiglecFhigh Cells Are Mature and Long-Lived Neutrophils , 2020, Cell Reports.

[8]  D. Gabrilovich.  All Myeloid-Derived Suppressor Cells Are Not Created Equal: How Gender Inequality Influences These Cells and Affects Cancer Therapy. , 2020, Cancer discovery.

[9]  F. Ginhoux,et al.  Combinatorial Single-Cell Analyses of Granulocyte-Monocyte Progenitor Heterogeneity Reveals an Early Uni-potent Neutrophil Progenitor. , 2020, Immunity.

[10]  T. Lüscher,et al.  Therapeutic Implications , 2020, The Endothelium: Modulator of Cardiovascular Function.

[11]  H. Wong,et al.  Olfactomedin 4 marks a subset of neutrophils in mice , 2018, Innate immunity.

[12]  Y. Sonoda,et al.  A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells , 2018, Nature Communications.

[13]  D. Gabrilovich,et al.  Plasticity of myeloid-derived suppressor cells in cancer. , 2018, Current opinion in immunology.

[14]  P. Dong,et al.  Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E , 2018, Cell Death & Disease.

[15]  Geert Raes,et al.  Beyond the M‐CSF receptor – novel therapeutic targets in tumor‐associated macrophages , 2018, The FEBS journal.

[16]  Y. Miyagi,et al.  High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers , 2018, Scientific Reports.

[17]  Chunsheng Zhang,et al.  Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. , 2017, Cancer cell.

[18]  C. Ries,et al.  Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy , 2017, Journal of Immunotherapy for Cancer.

[19]  H. Wong,et al.  Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock , 2017, Critical care medicine.

[20]  B. Xiong,et al.  The clinical significance and biological function of olfactomedin 4 in triple negative breast cancer. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  K. Leandersson,et al.  On the origin of myeloid-derived suppressor cells , 2016, Oncotarget.

[22]  Z. Granot,et al.  The diversity of circulating neutrophils in cancer. , 2017, Immunobiology.

[23]  P. Kubes,et al.  Monocyte Conversion During Inflammation and Injury. , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[24]  B. Skinner,et al.  Nuclear morphologies: their diversity and functional relevance , 2016, Chromosoma.

[25]  A. Zlotnik,et al.  Biological role of granulocyte macrophage colony‐stimulating factor (GM‐CSF) and macrophage colony‐stimulating factor (M‐CSF) on cells of the myeloid lineage , 2016, Journal of leukocyte biology.

[26]  George A. Dominguez,et al.  Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients , 2016, Science Immunology.

[27]  Peter J. Murray,et al.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards , 2016, Nature Communications.

[28]  X. Qin,et al.  Loss of OLFM4 promotes tumor migration through inducing interleukin-8 expression and predicts lymph node metastasis in early gastric cancer , 2016, Oncogenesis.

[29]  Alice Giustacchini,et al.  Distinct myeloid progenitor differentiation pathways identified through single cell RNA sequencing , 2016, Nature Immunology.

[30]  D. Gabrilovich,et al.  The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. , 2016, Trends in immunology.

[31]  Phillip G. Popovich,et al.  Novel Markers to Delineate Murine M1 and M2 Macrophages , 2015, PloS one.

[32]  D. Gabrilovich,et al.  Transcriptional regulation of myeloid‐derived suppressor cells , 2015, Journal of leukocyte biology.

[33]  C. Ries,et al.  CSF-1/CSF-1R targeting agents in clinical development for cancer therapy. , 2015, Current opinion in pharmacology.

[34]  W. Kim,et al.  Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer , 2015, Virchows Archiv.

[35]  M. Zenke,et al.  The clash of Langerhans cell homeostasis in skin: Should I stay or should I go? , 2015, Seminars in cell & developmental biology.

[36]  G. Natoli,et al.  Macrophages and cancer: from mechanisms to therapeutic implications. , 2015, Trends in immunology.

[37]  J. Pollard,et al.  Immune cell promotion of metastasis , 2015, Nature Reviews Immunology.

[38]  P. De Baetselier,et al.  Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression , 2014, Front. Immunol..

[39]  P. Trikha,et al.  Signaling pathways involved in MDSC regulation. , 2014, Biochimica et biophysica acta.

[40]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[41]  J. Blay,et al.  Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. , 2014, Cancer cell.

[42]  V. Bronte,et al.  Myeloid‐derived suppressor cell heterogeneity in human cancers , 2014, Annals of the New York Academy of Sciences.

[43]  E. Stanley,et al.  CSF-1 receptor signaling in myeloid cells. , 2014, Cold Spring Harbor perspectives in biology.

[44]  P. Carmeliet,et al.  Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population. , 2014, Cancer research.

[45]  L. Levy,et al.  Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression , 2013, Cancer Immunology, Immunotherapy.

[46]  M. Nussenzweig,et al.  Intestinal monocytes and macrophages are required for T cell polarization in response to Citrobacter rodentium , 2013, The Journal of experimental medicine.

[47]  S. Ricardo,et al.  Macrophages and CSF-1 , 2013, Organogenesis.

[48]  A. Karlsson,et al.  The Human Neutrophil Subsets Defined by the Presence or Absence of OLFM4 Both Transmigrate into Tissue In Vivo and Give Rise to Distinct NETs In Vitro , 2013, PloS one.

[49]  B. McFarlin,et al.  Mouse blood monocytes: standardizing their identification and analysis using CD115. , 2013, Journal of immunological methods.

[50]  Yulia Nefedova,et al.  Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer , 2012, Nature Immunology.

[51]  M. Diamond,et al.  IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia , 2012, Nature Immunology.

[52]  M. Starovasnik,et al.  Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R. , 2012, Structure.

[53]  A. Silahtaroglu,et al.  Olfactomedin 4 defines a subset of human neutrophils , 2012, Journal of leukocyte biology.

[54]  Yueqin Liu,et al.  Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis. , 2010, Blood.

[55]  P. De Baetselier,et al.  Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. , 2010, Cancer research.

[56]  D. Link,et al.  CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. , 2010, The Journal of clinical investigation.

[57]  Kazuhiro Yoshida,et al.  Serum olfactomedin 4 (GW112, hGC‐1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients , 2009, International journal of cancer.

[58]  Michelle Collazo,et al.  Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.

[59]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[60]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[61]  Weiping Zou,et al.  Immunosuppressive networks in the tumour environment and their therapeutic relevance , 2005, Nature Reviews Cancer.

[62]  Chuan-Yuan Li,et al.  GW112, A Novel Antiapoptotic Protein That Promotes Tumor Growth , 2004, Cancer Research.

[63]  A. Palucka,et al.  TNF Skews Monocyte Differentiation from Macrophages to Dendritic Cells 1 , 2003, The Journal of Immunology.

[64]  R. Russell,et al.  Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. , 2002, Blood.

[65]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[66]  D. Hume,et al.  Bacterial/CpG DNA down-modulates colony stimulating factor-1 receptor surface expression on murine bone marrow-derived macrophages with concomitant growth arrest and factor-independent survival. , 1999, Journal of immunology.

[67]  C. Barlow,et al.  Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[68]  K. Weinberg,et al.  A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. , 1997, Blood.

[69]  D. Liebermann,et al.  The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage , 1993, Cell.